MAIA Biotechnology, Inc. (MAIA) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
444 West Lake Street
Chicago, IL 60606
United States of America (the)
Phone
312 416 8592
Website
Sector
Healthcare
Industry
Biotechnology
Employees
13
First IPO Date
July 28, 2022
| Name | Title | Pay | Year Born |
| Vlad Vitoc | Co-Founder, President, Chief Executive Officer & Chairman of the Board of Directors | 960,152 | 1970 |
| Jeffrey C. Himmelreich | Head of Finance and Principal Financial & Accounting Officer | 351,386 | 1976 |
| Sergei Gryaznov | Chief Scientific Officer | 705,054 | 1960 |
| Linda Moreira | Company Secretary | 0 | N/A |
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.